Foundation Medicine (FMI) Misses Q3 EPS by 4c, Offers FY15 Guidance

Foundation Medicine (NASDAQ: FMI) reported Q3 EPS of ($0.60), $0.04 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24.04 million.

Foundation Medicine sees FY2015 revenue of $85-95 million, versus the consensus of $92.10 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c